Fixed drug eruption followed by lichen aureus during abatacept add-on therapy of rheumatoid arthritis

doi:10.3315/jdcr.2008.1018

Contents

Abstract
Keywords

Download PDF pdf

Download XML

523 Views

315 Downloads

Share this article

Research Article | Volume 2 Issue 4 (None, 2008) | Pages 49 - 51

Fixed drug eruption followed by lichen aureus during abatacept add-on therapy of rheumatoid arthritis

Uwe Wollina

Leonore Unger

Under a Creative Commons license

Open Access

DOI : 10.3315/jdcr.2008.1018

PMID : PMC3157784

Received

Oct. 30, 2008

Published

Dec. 27, 2008

Abstract

Background:Abatacept is a soluble fusion protein approved as add-on drug in rheumatoid arthritis.Main observations:Here we report the first case of fixed drug eruption followed by lichen aureus due to abatacept in a 67-year-old woman.Conclusion:Fixed drug eruption is an unexpected drug reaction for abatacept, since T-cell activation is inhibited.

Keywords

Abatacept

Rheumatoid arthritis

Drug reaction

Lichen aureus

Recommended Articles

Review Article

Bioceramic Materials for Root Repair and Regenerative Endodontics: A Narrative Review of Current Evidenc

Published: 06/10/2026